Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
Countries have shut down the economy to slow the spread of the coronavirus. Supermarket shelves remain stocked for now. But a protracted pandemic crisi s could quickly put a strai n on the f ood supply chains, a complex web of interactions involving farmers, agricultu...ral inputs, processing plants, shipping, retailers and more. The shipping industry is already reporting slowdowns because of port closures, and logistics hurd les could disrupt the supply chains in coming weeks.
more
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...h conceptually new and
rapid AST technologies have been described, including new phenotyping methods, digital
imaging and genomic approaches, there is no single major, or broadly accepted, technological
breakthrough that leads the field of rapid AST platform development
more
12 April 2020
This Guidance Note on making COVID-19 response Age & Disability-inclusive provides advice for organizations and sectors to ensure essential responses, communication about the outbreak and adapt to services and support are inclusive and accessible for older persons and persons with d...isabilities.
more
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
There has been a significant reduction in the number of displaced people - with 73,296 people currently hosted in 70 accommodation centres; down from 142,327 people the week before.
A total of 4,979 cholera cases were recorded in Beira, Dondo, Buzi and Nhamatanda and the death toll has reached eigh...t.
With UNICEF support, 814,293 people were vaccinated against cholera representing 99 per cent of the target population.
UNICEF continues supporting FIPAG (the water supply institution),
Government and operators to run water supply systems in affected areas providing drinking water to 771,856 people
more
This document, produced by IFRC, UNICEF and WHO, suggests key actions on how people and communities can stay safe and slow down the spread of COVID-19, particularly for contexts where you might have been asked by your local authorities to maintain physical distance or stay home.
Available in: Arabi...c, Bangla, Hindi, Indonesian, Japanese, Korean, Malay, Myanmar, Portuguese, Simplified Chinese, Spanish, Tagalog, Thai, Traditional Chinese, Vietnamese
https://communityengagementhub.org/resource/community-action-guide/
more
Initial reports indicate significant damage to Beira and surrounding areas, including destroyed houses.
• Sofala, Manica, Zambezia and Inhambane provinces have been hardest hit by the cyclone’s path and the preceding tropical depression.
• An inter-agency assessment team, led by the Nati...onal Institute of Disaster Management’s (INGC) Director, is on ground in Beira
more
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...ons and duration of hospital stay. Both the South African Thoracic Society (SATS) and Global Initiative for Chronic Obstructive Lung Disease (GOLD), guidelines recommend the use of long acting anticholinergic drugs (or long acting beta agonists) in moderate to very severe disease as defined by lung function (FEV1). The most up to date guideline, utilizing the GRADE methodology (European Respiratory Society guidelines of 2017), confirms their superiority over long acting β agonists (LABA) as monotherapy for COPD in that LAMA's have demonstrated greater efficacy in terms of exacerbation reduction, with similar safety profile.2 These recommnedations are supported by published peer-reviewed
evidence including individual papers and Cochrane reviews.
more
Report
A Project of the Joep Lange Institute July, 2018